Quarterly report · Q2
2385.TEDINET S100Q4ZE
Period2022-07-01 → 2022-12-31
Filed2023-02-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥4.2bn | 2022-07-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥9.3bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.2bn | 2021-07-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥345m | 2022-07-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥584m | 2021-07-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥345m | 2022-07-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥629m | 2021-07-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥345m | 2022-07-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥628m | 2021-07-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥209m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥810m | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥415m | 2021-07-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥213m | 2022-07-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥421m | 2021-07-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥8.0bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.1bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.0bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.9bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥6.8bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥6.5bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.5bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.0bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.5bn | at 2022-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.3bn | at 2021-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.3bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥328m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.2bn | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥27m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥245m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥23m | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥130m | 2022-07-01 → 2022-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥130m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥129m | 2021-07-01 → 2021-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥8 | 2022-07-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.47 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.95 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.86 | 2021-07-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.71 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 84.4% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.3% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 77.4% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 48
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2022-12-31 | −¥2m |
| Reconciling Itemsreconciling | revenue external | 2022-07-01 → 2022-12-31 | ¥900,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2022-12-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2022-12-31 | −¥155m |
| jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥258m |
| jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥258m |
| jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥32m |
| jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥2.0bn |
| jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥2.0bn |
| jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥398m |
| jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segment | segment profit | 2022-07-01 → 2022-12-31 | −¥18m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥279m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥277m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥3m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥43m |
| jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segment | revenue | 2022-07-01 → 2022-12-31 | ¥314m |
| jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segment | revenue external | 2022-07-01 → 2022-12-31 | ¥314m |
| jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segment | segment profit | 2022-07-01 → 2022-12-31 | ¥45m |
| —segment total | revenue | 2022-07-01 → 2022-12-31 | ¥4.2bn |
| —segment total | revenue external | 2022-07-01 → 2022-12-31 | ¥4.2bn |
| —segment total | revenue intersegment | 2022-07-01 → 2022-12-31 | ¥3m |
| —segment total | segment profit | 2022-07-01 → 2022-12-31 | ¥500m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2021-12-31 | −¥2m |
| Reconciling Itemsreconciling | revenue external | 2021-07-01 → 2021-12-31 | ¥900,000 |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2021-12-31 | −¥3m |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2021-12-31 | −¥162m |
| jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥231m |
| jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥231m |
| jpcrp040300-q2r_E05367-000Clinical Evidence Servicereportable segment | segment profit | 2021-07-01 → 2021-12-31 | −¥6m |
| jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥2.7bn |
| jpcrp040300-q2r_E05367-000Functional Cosmetic Retailingreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥659m |
| jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥1.6bn |
| jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥1.6bn |
| jpcrp040300-q2r_E05367-000Functional Food Retailingreportable segment | segment profit | 2021-07-01 → 2021-12-31 | −¥22m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥360m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥358m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | revenue intersegment | 2021-07-01 → 2021-12-31 | ¥3m |
| jpcrp040300-q2r_E05367-000Functional Material Developmentreportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥63m |
| jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segment | revenue | 2021-07-01 → 2021-12-31 | ¥315m |
| jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segment | revenue external | 2021-07-01 → 2021-12-31 | ¥315m |
| jpcrp040300-q2r_E05367-000Health Care Support Servicereportable segment | segment profit | 2021-07-01 → 2021-12-31 | ¥52m |
| —segment total | revenue | 2021-07-01 → 2021-12-31 | ¥5.2bn |
| —segment total | revenue external | 2021-07-01 → 2021-12-31 | ¥5.1bn |
| —segment total | revenue intersegment | 2021-07-01 → 2021-12-31 | ¥3m |
| —segment total | segment profit | 2021-07-01 → 2021-12-31 | ¥746m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 442
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)あると築地有限責任監査法人 | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)長井 完文 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)曽川 俊洋 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1YTDDuration | 5150509000 | JPY |
| Net sales (5-year summary) | CurrentYTDDuration | 4223839000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 9347879000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YTDDuration | 629243000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYTDDuration | 345351000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 1253893000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YTDDuration | 414987000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | CurrentYTDDuration | 209204000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 809710000 | JPY |
| Comprehensive income (5-year summary) | Prior1YTDDuration | 421405000 | JPY |
| Comprehensive income (5-year summary) | CurrentYTDDuration | 213305000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 817198000 | JPY |
| Net assets (5-year summary) | Prior1QuarterInstant | 6451573000 | JPY |
| Net assets (5-year summary) | CurrentQuarterInstant | 6929881000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6847367000 | JPY |
| Total assets (5-year summary) | Prior1QuarterInstant | 8078725000 | JPY |
| Total assets (5-year summary) | CurrentQuarterInstant | 7969219000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 8489524000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1YTDDuration | 15.86 | |
| Basic earnings loss per share (5-year summary) | CurrentYTDDuration | 8.00 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 30.95 | |
| Diluted earnings per share (5-year summary) | Prior1YTDDuration | － | |
| Diluted earnings per share (5-year summary) | CurrentYTDDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1QuarterInstant | 0.774 | |
| Equity to asset ratio (5-year summary) | CurrentQuarterInstant | 0.844 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.783 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1YTDDuration | 1232200000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | CurrentYTDDuration | -327897000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 2135970000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YTDDuration | -23352000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | CurrentYTDDuration | -27023000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -244577000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YTDDuration | -129469000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYTDDuration | -129936000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -129944000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1QuarterInstant | 5335183000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentQuarterInstant | 5532396000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 6017253000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1QuarterDuration | 12.71 | |
| Basic earnings loss per share (5-year summary) | CurrentQuarterDuration | 7.47 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 26158200 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 26158200 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 26158200 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 26158200 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |